A detailed history of Fieldpoint Private Securities, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 60 shares of CTLT stock, worth $3,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 245 75.51%
Holding current value
$3,579
Previous $27,000 77.78%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$87.2 - $114.05 $16,132 - $21,099
-185 Reduced 75.51%
60 $6,000
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $1,637 - $2,135
15 Added 6.52%
245 $33,000
Q4 2020

Jan 28, 2021

BUY
$85.88 - $105.36 $19,752 - $24,232
230 New
230 $24,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.